Myeloid ACAT1/SOAT1: a novel regulator of dyslipidemia and retinal neovascularization

Abstract Pathological retinal neovascularization (RNV) is a major cause of vision loss and blindness during ischemic retinopathies. Our investigations in the mouse model of oxygen-induced retinopathy (OIR) demonstrate a novel mechanism of pathological RNV and neurovascular injury. We show that OIR-i...

Full description

Saved in:
Bibliographic Details
Main Authors: Syed A. H. Zaidi, Ruth B. Caldwell, Modesto A. Rojas
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:npj Metabolic Health and Disease
Online Access:https://doi.org/10.1038/s44324-024-00046-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832595015408287744
author Syed A. H. Zaidi
Ruth B. Caldwell
Modesto A. Rojas
author_facet Syed A. H. Zaidi
Ruth B. Caldwell
Modesto A. Rojas
author_sort Syed A. H. Zaidi
collection DOAJ
description Abstract Pathological retinal neovascularization (RNV) is a major cause of vision loss and blindness during ischemic retinopathies. Our investigations in the mouse model of oxygen-induced retinopathy (OIR) demonstrate a novel mechanism of pathological RNV and neurovascular injury. We show that OIR-induced activation of macrophage/microglial cells, retinal inflammation, and pathological RNV are mediated by increases in cholesterol ester (CE) formation due to activation of the acyl-CoA: Cholesterol Acyltransferase 1/Sterol O-Acyltransferase 1 (ACAT1/SOAT1) enzyme.
format Article
id doaj-art-f6b49136966546abb100d320a7b20745
institution Kabale University
issn 2948-2828
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series npj Metabolic Health and Disease
spelling doaj-art-f6b49136966546abb100d320a7b207452025-01-19T12:10:10ZengNature Portfolionpj Metabolic Health and Disease2948-28282025-01-01311610.1038/s44324-024-00046-xMyeloid ACAT1/SOAT1: a novel regulator of dyslipidemia and retinal neovascularizationSyed A. H. Zaidi0Ruth B. Caldwell1Modesto A. Rojas2Vascular Biology Center, Augusta UniversityVascular Biology Center, Augusta UniversityVascular Biology Center, Augusta UniversityAbstract Pathological retinal neovascularization (RNV) is a major cause of vision loss and blindness during ischemic retinopathies. Our investigations in the mouse model of oxygen-induced retinopathy (OIR) demonstrate a novel mechanism of pathological RNV and neurovascular injury. We show that OIR-induced activation of macrophage/microglial cells, retinal inflammation, and pathological RNV are mediated by increases in cholesterol ester (CE) formation due to activation of the acyl-CoA: Cholesterol Acyltransferase 1/Sterol O-Acyltransferase 1 (ACAT1/SOAT1) enzyme.https://doi.org/10.1038/s44324-024-00046-x
spellingShingle Syed A. H. Zaidi
Ruth B. Caldwell
Modesto A. Rojas
Myeloid ACAT1/SOAT1: a novel regulator of dyslipidemia and retinal neovascularization
npj Metabolic Health and Disease
title Myeloid ACAT1/SOAT1: a novel regulator of dyslipidemia and retinal neovascularization
title_full Myeloid ACAT1/SOAT1: a novel regulator of dyslipidemia and retinal neovascularization
title_fullStr Myeloid ACAT1/SOAT1: a novel regulator of dyslipidemia and retinal neovascularization
title_full_unstemmed Myeloid ACAT1/SOAT1: a novel regulator of dyslipidemia and retinal neovascularization
title_short Myeloid ACAT1/SOAT1: a novel regulator of dyslipidemia and retinal neovascularization
title_sort myeloid acat1 soat1 a novel regulator of dyslipidemia and retinal neovascularization
url https://doi.org/10.1038/s44324-024-00046-x
work_keys_str_mv AT syedahzaidi myeloidacat1soat1anovelregulatorofdyslipidemiaandretinalneovascularization
AT ruthbcaldwell myeloidacat1soat1anovelregulatorofdyslipidemiaandretinalneovascularization
AT modestoarojas myeloidacat1soat1anovelregulatorofdyslipidemiaandretinalneovascularization